Jasmine Side Effects

8402818-7 | Pregnancy On Oral Contraceptive, Abortion Induced
on May 30, 2012 Female patient from FRANCE , 30 years of age, was diagnosed with oral contraception and was treated with Jasmine(View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy on oral contraceptive, abortion induced. Jasmine dosage: 1 Df, Unk.

8058132-5 | Dysarthria, Social Avoidant Behaviour, Chorea, Cognitive Disorder
Patient was taking Jasmine (View Usage). Patient had the following side effects: dysarthria, social avoidant behaviour, chorea, cognitive disorder on Jan 17, 2012 from FRANCE Additional patient health information: Female patient , 16 years of age, was diagnosed with oral contraception and. Jasmine dosage: 1 Df, Qd. Patient was hospitalized.

7844017-3 | Pancreatitis Acute, Abdominal Pain
Adverse event was reported on Oct 14, 2011 by a Female patient taking Jasmine (View Usage) (Dosage: Unk) was diagnosed with oral contraception, cough and. Location: FRANCE , 33 years of age, After Jasmine was administered, patient had the following side effects: pancreatitis acute, abdominal pain (What is abdominal pain?). During the same period patient was treated with TUSSIPAX ORAL (Unk) (View Tussipax Oral Review and Tussipax Oral Label ). Patient was hospitalized.

7716113-2 | Abortion Spontaneous, Maternal Exposure Before Pregnancy
on Jun 14, 2011 Female patient from SOUTH AFRICA , weighting 152.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Jasmine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, maternal exposure before pregnancy. Jasmine dosage: . During the same period patient was treated with SUSTIVA (600mg At Night) (View Sustiva Review and Sustiva Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), COMBIVIR (View Combivir Review and Combivir Label ), TRUVADA (View Truvada Review and Truvada Label ).


7708430-7 | Hereditary Angioedema, Abdominal Pain, Tongue Oedema, Subileus
on Apr 04, 2011 Female patient from FRANCE , 29 years of age, was diagnosed with oral contraception and was treated with Jasmine(View Usage). Patient had the following side effects: hereditary angioedema, abdominal pain (What is abdominal pain?), tongue oedema, subileus. Jasmine dosage: Unk. During the same period patient was treated with DIANE (View Diane Review and Diane Label ). Patient was hospitalized.

7674122-6 | Chorea, Dysarthria, Cognitive Disorder, Social Avoidant Behaviour
Patient was taking Jasmine (View Usage). After Jasmine was administered, patient had the following side effects: chorea, dysarthria, cognitive disorder, social avoidant behaviour on Aug 04, 2011 from FRANCE Additional patient health information: Female patient , 16 years of age, was diagnosed with oral contraception and. Jasmine dosage: 1 Df, Qd. Patient was hospitalized.

7473675-0 | Pain In Extremity, Pulmonary Embolism, Headache, Deep Vein Thrombosis, Mental Disorder, Oedema Peripheral, Dyspnoea
Adverse event was reported on Apr 25, 2011 by a Female patient taking Jasmine (View Usage) (Dosage: ) was diagnosed with polycystic ovaries, pain (What is pain?) and. Location: UNITED STATES , 32 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: pain in extremity, pulmonary embolism (What is pulmonary embolism?), headache (What is headache?), deep vein thrombosis (What is deep vein thrombosis?), mental disorder, oedema peripheral, dyspnoea. During the same period patient was treated with YASMIN (Unk Unk, Qd) (View Yasmin Review and Yasmin Label ), NONSTEROIDALS (View Nonsteroidals Review and Nonsteroidals Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), ANAPROX (It Will Need To Stop When Her Inr Is Therapeutic) (View Anaprox Review and Anaprox Label ), NORFLEX (View Norflex Review and Norflex Label ). Patient was hospitalized.

7282900-0 | Pulmonary Embolism, Coma, Cardiac Arrest, Chest Pain
on Feb 02, 2011 Female patient from TUNISIA , 26 years of age, was treated with Jasmine (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?), coma, cardiac arrest (What is cardiac arrest?), chest pain (What is chest pain?). Jasmine dosage: Unk. Patient was hospitalized.

7174531-8 | Focal Nodular Hyperplasia
on Nov 17, 2010 Female patient from FRANCE , 39 years of age, was diagnosed with acne (What is acne?), contraception, hirsutism and was treated with Jasminelle(View Usage). After Jasmine was administered, patient had the following side effects: focal nodular hyperplasia. Jasminelle dosage: . During the same period patient was treated with MIRENA (20 ?g Intra-uterine) (View Mirena Review and Mirena Label ).

5522620-3 | Chest Pain, Deep Vein Thrombosis, Pain In Extremity, Pelvic Venous Thrombosis
Patient was taking Jasmine (21) (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), pain in extremity, pelvic venous thrombosis on Nov 20, 2007 from FRANCE Additional patient health information: Female patient , 19 years of age, weighting 119.0 lb, was diagnosed with ovulation pain and. Jasmine (21) dosage: 1 Tab(s), 21d/28d. Patient was hospitalized.

5488881-4 | Chest Pain, Deep Vein Thrombosis, Pelvic Venous Thrombosis
Adverse event was reported on Oct 15, 2007 by a Female patient taking Jasmine (21) (View Usage) (Dosage: 1 Tab(s), 21d/28d) was diagnosed with ovulation pain and. Location: FRANCE , 19 years of age, Patient had the following side effects: chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), pelvic venous thrombosis. Patient was hospitalized.

5373735-4 | Erythema Nodosum, Polyarthritis
on Jun 21, 2007 Female patient from FRANCE , 28 years of age, weighting 94.80 lb, was diagnosed with oral contraception and was treated with Jasmine (21) (View Usage). After Jasmine was administered, patient had the following side effects: erythema nodosum, polyarthritis. Jasmine (21) dosage: . During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), STRESAM (View Stresam Review and Stresam Label ), NOCTRAN 10 (View Noctran 10 Review and Noctran 10 Label ). Patient was hospitalized.

5107795-2 | Asthenia, Eosinophilia, Myalgia, Neutropenia, Pyrexia, Serum Ferritin Decreased, Thrombocythaemia, Viral Infection
on Sep 05, 2006 Female patient from FRANCE , 19 years of age, was diagnosed with oral contraception, viral infection (What is viral infection?) and was treated with Jasmine (drospirenone, Ethinylestradiol)film Tablet(View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, eosinophilia, myalgia, neutropenia, pyrexia, serum ferritin decreased, thrombocythaemia, viral infection (What is viral infection?). Jasmine (drospirenone, Ethinylestradiol)film Tablet dosage: 1 Df, 1x/day, Oral. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5103109-2 | Blood Aldosterone Increased, Cellulitis, Oedema Peripheral, Urine Output Decreased
Patient was taking Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage). Patient had the following side effects: blood aldosterone increased, cellulitis (What is cellulitis?), oedema peripheral, urine output decreased on Aug 28, 2006 from FRANCE Additional patient health information: Female patient , 23 years of age, weighting 119.0 lb, was diagnosed with oral contraception and. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab (s), 21d/28d, Oral. Patient was hospitalized.

5089143-X | Disease Recurrence, Myopia
Adverse event was reported on Aug 18, 2006 by a Female patient taking Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage) (Dosage: 1 Tab (s), 21d/28d, Oral) was diagnosed with oral contraception and. Location: FRANCE , 35 years of age, After Jasmine was administered, patient had the following side effects: disease recurrence, myopia.

5023238-1 | Hyperaldosteronism, Hyperkalaemia, Hypertriglyceridaemia, Weight Increased
on May 30, 2006 Female patient from FRANCE , 19 years of age, was treated with Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage). Patient experienced the following unwanted or unexpected effects: hyperaldosteronism, hyperkalaemia, hypertriglyceridaemia, weight increased. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: .

5019267-4 | Gamma-glutamyltransferase Increased, Hypercholesterolaemia, Hypertriglyceridaemia, Renal Failure
on May 23, 2006 Female patient from FRANCE , 32 years of age, was treated with Jasmine (ethinylestradiol, Drospirenone) Film Tablet(View Usage). Patient had the following side effects: gamma-glutamyltransferase increased, hypercholesterolaemia, hypertriglyceridaemia, renal failure. Jasmine (ethinylestradiol, Drospirenone) Film Tablet dosage: 1 Tab(s), 21d/28d, Oral.

5015803-2 | Gamma-glutamyltransferase Increased, Hypercholesterolaemia, Hypertriglyceridaemia, Renal Failure
Patient was taking Jasmine (ethinyestradiol, Drospirenone) Film Tablet (View Usage). After Jasmine was administered, patient had the following side effects: gamma-glutamyltransferase increased, hypercholesterolaemia, hypertriglyceridaemia, renal failure on May 23, 2006 from FRANCE Additional patient health information: Female patient , 32 years of age, . Jasmine (ethinyestradiol, Drospirenone) Film Tablet dosage: 1 Tabs 21d/28d Oral.

4785927-3 | Balance Disorder, Condition Aggravated, Fall, Myoclonic Epilepsy
Adverse event was reported on Sep 16, 2005 by a Female patient taking Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage) (Dosage: 1 Tab (s), 21d/28d, Oral) was diagnosed with oral contraception and. Location: FRANCE , 18 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: balance disorder, condition aggravated, fall (What is fall?), myoclonic epilepsy. Patient was hospitalized.

4761052-2 | Epilepsy, Therapeutic Response Decreased
on Aug 17, 2005 Female patient from FRANCE , 18 years of age, was diagnosed with oral contraception and was treated with Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?), therapeutic response decreased. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab(s),21d/28, Oral.

4675119-0 | Raynaud's Phenomenon
on May 15, 2005 Female patient from , 19 years of age, was diagnosed with oedema and was treated with Jasmine(drospirenone, Ethinylestradiol) Film Tablet(View Usage). After Jasmine was administered, patient had the following side effects: raynaud's phenomenon. Jasmine(drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab(s), 21d/28d, Oral.

4609609-3 | Disease Recurrence, Myopia
Patient was taking Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, myopia on Mar 01, 2005 from Additional patient health information: Female patient , 35 years of age, was diagnosed with oral contraception and. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab(s), 21d/28 D, Oral.

4603251-6 | Diarrhoea, Enterocolitis Haemorrhagic, Proctocolitis, Protein C Deficiency, Protein S Deficiency, Splenic Vein Thrombosis
Adverse event was reported on Feb 21, 2005 by a Female patient taking Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage) (Dosage: 1 Tab (s), 21d/28d, Oral) was diagnosed with oral contraception and. Location: , 29 years of age, weighting 114.6 lb, Patient had the following side effects: diarrhoea, enterocolitis haemorrhagic, proctocolitis, protein c deficiency, protein s deficiency, splenic vein thrombosis. Patient was hospitalized.

4586733-5 | Phlebitis, Phlebitis Superficial, Retinal Vascular Disorder
on Feb 01, 2005 Female patient from , 43 years of age, was diagnosed with oral contraception and was treated with Jasmine (drospirenone, Ethinylestradiol) Film Tablet (View Usage). After Jasmine was administered, patient had the following side effects: phlebitis, phlebitis superficial, retinal vascular disorder. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab(s), 21d/28d, Oral.

4553305-8 | Amenorrhoea, Gingival Bleeding, Thrombocythaemia
on Dec 28, 2004 Female patient from , 32 years of age, weighting 105.8 lb, was diagnosed with oral contraception and was treated with Jasmine (drospirenone, Ethinylestradiol) Film Tablet(View Usage). Patient experienced the following unwanted or unexpected effects: amenorrhoea, gingival bleeding, thrombocythaemia. Jasmine (drospirenone, Ethinylestradiol) Film Tablet dosage: 1 Tab(s), 21d/28d, Oral.